Claris has positioned itself as a company specialising in sterile injectables technology. Our array of therapies includes anesthesia, blood products, anti-infectives, and plasma volume expanders.
We cater across several products and categories in India and continuously strive for upgradation of medical care in the country with the introduction of breakthrough products and technologies.
Our customer base in India includes institutions, large corporate hospitals, and nursing homes.
In accordance with our commitment to work for the betterment of healthcare in the country, we remain at the forefront to adopt creative initiatives & training methods for staying abreast with the latest industry trends. We contribute towards medical education through participating in several nation-wide congresses & conventions, conducting various Continuous Medical Education (CME) Meets & Doctor Group Meets (DGMs) across the country covering renowned doctors, and other such initiatives.
Our market presence is widely spread across the globe including Regulated Markets and Emerging Markets.
Our major focus in Regulated Markets is on countries like USA, UK, Australia, New Zealand, The Netherlands, Italy, Germany, Canada, South Africa, Hong Kong, Korea, etc., where we have robust sales & distribution network. Our long-term growth and increased profitability in operations will continue with the year after year increasing contribution from these Regulated Markets.
The presence in Emerging Markets includes the regions of Asia, Africa, CIS, MEGNA (Middle East, Gulf & North Africa), Russia, and Latin America, where the marketing strategy is to enhance company's visibility at a global forefront and connect with customers & business associates.
One of the critical success factors for manufacturing and marketing pharmaceutical products for international markets is the regulatory approvals for the manufacturing unit which include US FDA, MHRA (UK), TGA (Australia), and GCC FDCA.
Our augmenting visibility at global front and the interaction with customers & business associates has empowered us to participate at various international conferences and seminars all around the globe.
For Claris, international business has always remained an area of successful strategic business growth and will remain so in the years to come.
Claris Otsuka deals in infusion products across therapeutic segments including infusion therapy, parenteral nutrition, anti-infectives, and plasma volume expanders.
The company has its sales & distribution network across major Emerging Markets and is constantly working in the direction of providing improved health to people across the world.
Claris Otsuka caters across several product categories in India with an endeavour to support upgradation of medical care in the country with the introduction of new products and technologies. The customer base of Claris Otsuka in India includes institutions, large corporate hospitals, and nursing homes.
Claris Otsuka has its market presence across the globe, through a sales & distribution network spread across various Emerging Markets in the regions of Asia, Africa, CIS, MEGNA (Middle East, Gulf & North Africa), Russia, and Latin America. The marketing strategy to enhance the company's visibility at a global forefront and to connect with customers & business associates has led it to focus on international conferences and seminars around the world.
Visit www.clarisotsuka.com for more information about the company including products and manufacturing capabilities.